was born in Canada. He obtained his Honour’s Bachelor of Medical Science Degree in Clinical Biochemistry from the University of Western Ontario in 2009. During his undergraduate degree, he undertook a research project investigating “The roles of Insulin-like Growth Factor Binding Protein 6 (IGFBP-6) in Dupuytren’s Disease” under the supervision of Drs. David O’Gorman and Bing Siang Gan at the Cell and Molecular Biology Laboratory of the Roth/McFarlane Hand and Upper Limb Centre at the Lawson Health Research Institute in London, Canada. In 2009, he was awarded a Canadian Institutes of Health Research Summer Studentship in Musculoskeletal Research and focused on the “Generation of lox-stop-lox POSTN cDNA transgene,” under the supervision of Dr. David O’Gorman. In 2014, he obtained his PhD in Biochemistry from the University of Western Ontario, also under the supervision of Dr. David O’Gorman. His thesis was entitled “The roles of matrix-associated periostin in an in vitro model of hypertrophic scarring.” During his PhD, Justin received the Frederick Banting and Charles Best Canada Scholarship award in 2010 for his work on “periostin in abnormal wound healing,” the Young Investigators Award from the European Tissue Repair Society in 2010 and a Canadian Institutes of Health Research Community Travel Award in 2012. In 2014, he became laboratory manager of the Cell and Molecular Biology Laboratory of the Roth/McFarlane Hand and Upper Limb Centre. There, his focus was on designing and optimizing 3D, mechanical-based assays for studies involving Dupuytren’s Disease and shoulder fibrosis. In 2015 he moved to the Netherlands and is currently working as a Scientist in the New Technology Development team at Galapagos BV.
2009 BMSc, Clinical Biochemistry, Faculty of Biochemisty, Schulich School of Medicine & Dentistry, University of Western Ontario
2014 PhD, Biochemistry, Faculty of Biochemisty, Schulich School of Medicine & Dentistry, University of Western Ontario
Crawford J, Raykha C, Charles D, Gan BS, O'Gorman DB. (2015) WT1 expression is increased in primary fibroblasts derived from Dupuytren's disease tissues. J Cell Commun Signal. [Epub ahead of print]
Crawford J, Nygard K, Gan BS, O'Gorman DB. (2015) Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.Exp Dermatol. Feb;24(2):120-6. doi: 10.1111/exd.12601.
Raykha CN, Crawford JD, Burry AF, Drosdowech DS, Faber KJ, Gan BS, O'Gorman DB (2014) IGF2 expression and β-catenin levels are increased in Frozen Shoulder Syndrome. Clin Invest Med. Aug 1;37(4):E262-7.
Raykha C, Crawford J, Gan BS, Fu P, Bach LA, O'Gorman DB. (2013) IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease. Biochim Biophys Acta.Oct;1832(10):1511-9. doi: 10.1016/j.bbadis.2013.04.018.
Raykha C, Crawford J, Gan BS, O'Gorman DB. (2011) Insulin-like Growth Factor Binding Protein (IGFBP)-6: A mediator of myofibroblast differentiation in Dupuytren’s Disease. In: Proceedings of the International Dupuytren’s Symposium. Springer Verlag.